Abstract

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTNew Horizons in Drug Discovery - Understanding and Advancing Different Types of Kinase Inhibitors: Seven Years in Kinase Inhibitor Research with Impressive Achievements and New Future ProspectsStefan LauferStefan LauferMore by Stefan Lauferhttps://orcid.org/0000-0001-6952-1486 and Jürgen BajorathJürgen BajorathMore by Jürgen Bajorathhttps://orcid.org/0000-0002-0557-5714Cite this: J. Med. Chem. 2022, 65, 2, 891–892Publication Date (Web):December 23, 2021Publication History Published online23 December 2021Published inissue 27 January 2022https://doi.org/10.1021/acs.jmedchem.1c02126Copyright © Published 2021 by American Chemical SocietyRIGHTS & PERMISSIONSArticle Views5177Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (1 MB) Get e-AlertsSUBJECTS:Kinase inhibitors,Inhibitors,Peptides and proteins,Pharmaceuticals,Drug discovery Get e-Alerts

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.